Population Genetics

Developing and out-licensing biochemical tools and approaches for NGS applications

placeCambridge, England, United Kingdom calendar_todayFounded 2005 groups5 employees language populationgenetics.com

Innovation

20 patent families (15 granted) — focus: Chemistry & metallurgy; filing pace dormant. Cited 4,551 times.

YearFilings
20128
20139
20143
20156
20164
20174
20183
20201

Investor mix

6 investors on record; lead investors include Syngenta Group Ventures, Auriga Partners, ProVen VCT, Noble Fund Managers; 1 has since exited.

Investor typeCountShare
Venture capital350%
Other / undisclosed350%
Coming soon